What is Cullinan Therapeutics Receivables Turnover?
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Cullinan Therapeutics's Revenue for the
three
months ended in Dec. 2024 was $0.00 Mil. Cullinan Therapeutics's average Accounts Receivable for the
three
months ended in Dec. 2024 was $0.00 Mil.
Cullinan Therapeutics Receivables Turnover Historical Data
The historical data trend for Cullinan Therapeutics's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cullinan Therapeutics's Receivables Turnover
For the Biotechnology subindustry, Cullinan Therapeutics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cullinan Therapeutics's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cullinan Therapeutics's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Cullinan Therapeutics's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Cullinan Therapeutics Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Cullinan Therapeutics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CGEM has been successfully added to your 